PMID: 41742335
Oral GLP-1 receptor agonists for the treatment of obesity: ATTAINing metabolic benefits to find the OASIS.
Vafeidou Kyriaki, Koufakis Theocharis, Stavropoulos Konstantinos, Zarfeiadou Maria, Doumas Michael, Patoulias Dimitrios
Expert review of endocrinology & metabolism · 2026
Vol. 21, Issue 2, pp. 107-109
This entry links to third-party literature. For research use only.